-
1
-
-
0035353725
-
Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature
-
Ahlskog JE, Muenter MD, Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature, Mov Disord, 2001;16:448-58.
-
(2001)
Mov Disord
, vol.16
, pp. 448-458
-
-
Ahlskog, J.E.1
Muenter, M.D.2
-
2
-
-
22844442544
-
Identification of motor and nonmotor wearing-off in Parkinsońs disease: Comparison of a patient questionnaire versus a clinician assessment
-
Stacy M, Bowron A, Guttman M, et al. Identification of motor and nonmotor wearing-off in Parkinsońs disease: comparison of a patient questionnaire versus a clinician assessment, Mov Disord, 2005;20:726-33.
-
(2005)
Mov Disord
, vol.20
, pp. 726-733
-
-
Stacy, M.1
Bowron, A.2
Guttman, M.3
-
3
-
-
0031770529
-
Young-onset Parkinson's disease revisited: Clinical features, natural history, and mortality
-
Schrag A, Ben-Shlomo Y, Brown R, et al. Young-onset Parkinson's disease revisited: clinical features, natural history, and mortality, Mov Disord, 1998;13:885-94.
-
(1998)
Mov Disord
, vol.13
, pp. 885-894
-
-
Schrag, A.1
Ben-Shlomo, Y.2
Brown, R.3
-
4
-
-
33745605176
-
Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease
-
Olanow CW, Obeso JA, Stocchi F, Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease, Nat Clin Pract Neurol, 2006;2:382-92.
-
(2006)
Nat Clin Pract Neurol
, vol.2
, pp. 382-392
-
-
Olanow, C.W.1
Obeso, J.A.2
Stocchi, F.3
-
5
-
-
0035200697
-
Duodenal levodopa infusion in Parkinson's disease-long-term experience
-
Nilsson D, Nyholm D, Aquilonius SM, Duodenal levodopa infusion in Parkinson's disease-long-term experience, Acta Neurol Scand, 2001;104:343-8.
-
(2001)
Acta Neurol Scand
, vol.104
, pp. 343-348
-
-
Nilsson, D.1
Nyholm, D.2
Aquilonius, S.M.3
-
6
-
-
34249883912
-
Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose
-
APO303 Study Investigators
-
Pahwa R, Koller WC, Trosch RM, Sherry JH, APO303 Study Investigators. Subcutaneous apomorphine in patients with advanced Parkinson's disease: a dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose, J Neurol Sci, 2007;258:137-43.
-
(2007)
J Neurol Sci
, vol.258
, pp. 137-143
-
-
Pahwa, R.1
Koller, W.C.2
Trosch, R.M.3
Sherry, J.H.4
-
7
-
-
20444374478
-
Apomorphine Injection Therapy for Parkinson's Disease
-
Odin P, Apomorphine Injection Therapy for Parkinson's Disease, Akt Neurol, 2005;32:50-55.
-
(2005)
Akt Neurol
, vol.32
, pp. 50-55
-
-
Odin, P.1
-
8
-
-
4644329091
-
Subcutaneous apomorphine
-
Deleu D, Hanssens Y, Northway MG, Subcutaneous apomorphine. An evidence-based review of its use in Parkinsońs disease, Drugs Aging, 2004;21:687-709.
-
(2004)
An evidence-based review of its use in Parkinsońs disease, Drugs Aging
, vol.21
, pp. 687-709
-
-
Deleu, D.1
Hanssens, Y.2
Northway, M.G.3
-
9
-
-
0031923068
-
Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease
-
Colzi A, Turner K, Lees AJ, Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease, J Neurol Neurosurg Psychiatry, 1998;64:573-6.
-
(1998)
J Neurol Neurosurg Psychiatry
, vol.64
, pp. 573-576
-
-
Colzi, A.1
Turner, K.2
Lees, A.J.3
-
10
-
-
52649108045
-
Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
-
García Ruiz PJ, Sesar Ignacio A, Ares Pensado B, et al. Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study, Mov Disord, 2008;23:1130-36.
-
(2008)
Mov Disord
, vol.23
, pp. 1130-1136
-
-
García Ruiz, P.J.1
Sesar Ignacio, A.2
Ares Pensado, B.3
-
11
-
-
20144366287
-
Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using singledose challenges
-
Katzenschlager R, Hughes A, Evans A, et al. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using singledose challenges, Mov Disord, 2005;20:151-7.
-
(2005)
Mov Disord
, vol.20
, pp. 151-157
-
-
Katzenschlager, R.1
Hughes, A.2
Evans, A.3
-
12
-
-
0036869028
-
Apomorphine Monotherapy in the treatment of refractory motor complications of Parkinson's Disease-A long-term follow-up study of 64 patients
-
Manson AJ, Turner K, Lees AJ, Apomorphine Monotherapy in the treatment of refractory motor complications of Parkinson's Disease-A long-term follow-up study of 64 patients, Mov Disord, 2002;17:1235-41.
-
(2002)
Mov Disord
, vol.17
, pp. 1235-1241
-
-
Manson, A.J.1
Turner, K.2
Lees, A.J.3
-
13
-
-
12144278731
-
Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease
-
Alegret M, Valldeoriola F, Marti M, et al. Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease, Mov Disord, 2004;19:1463-9.
-
(2004)
Mov Disord
, vol.19
, pp. 1463-1469
-
-
Alegret, M.1
Valldeoriola, F.2
Marti, M.3
-
14
-
-
33645567169
-
Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus
-
De Gaspari D, Siri C, Landi A, et al. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus, J Neurol Neurosurg Psychiatry, 2006;77:450-53.
-
(2006)
J Neurol Neurosurg Psychiatry
, vol.77
, pp. 450-453
-
-
De Gaspari, D.1
Siri, C.2
Landi, A.3
-
15
-
-
3042647039
-
Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: A follow-up of two years
-
Morgante L, Basile G, Epifanio A, et al. Continuous apomorphine infusion (CAI) and neuropsychiatric disorders in patients with advanced Parkinson's disease: a follow-up of two years, Arch Gerontol Geriatr Suppl, 2004; (9):291-6.
-
(2004)
Arch Gerontol Geriatr Suppl
, Issue.9
, pp. 291-296
-
-
Morgante, L.1
Basile, G.2
Epifanio, A.3
|